Press release
mRNA Vaccine and Therapeutics Market to Hit USD 127.8 Billion by 2034, Growing at 10.7% CAGR
mRNA Vaccine and Therapeutics Market
The global success of COVID-19 vaccines by Moderna and Pfizer-BioNTech not only validated the mRNA platform but also transformed the landscape of drug development. What was once considered an experimental approach is now a multi-billion-dollar industry fueling next-generation vaccines and therapeutics.
mRNA technology offers significant advantages: rapid design and manufacturing, high potency, and adaptability against emerging pathogens. Beyond infectious diseases, it is now being explored for oncology, rare genetic disorders, and protein-replacement therapies. With governments, biopharma giants, and startups investing heavily, the mRNA vaccine and therapeutics market is poised for exponential growth through 2034.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72890
Market Overview
• Market Size (2024): USD 46.5 billion (estimated)
• Forecast (2034): USD 127.8 billion
• CAGR (2024-2034): ~10.7%
Key Growth Drivers:
• Continued global demand for COVID-19 and influenza mRNA vaccines.
• Expanding oncology-focused pipeline of mRNA therapeutics.
• Advancements in delivery technologies (lipid nanoparticles, polymer-based carriers).
• Rising government and private-sector funding for pandemic preparedness.
Challenges:
• Cold-chain storage and distribution hurdles.
• High production costs compared to traditional vaccines.
• Safety concerns and regulatory complexity for first-in-class mRNA drugs.
Leading Companies:
Pfizer Inc., BioNTech SE, Moderna Inc., CureVac AG, Sanofi, Gilead Sciences, Arcturus Therapeutics, Translate Bio (Sanofi), Moderna Therapeutics, AstraZeneca, and Vertex Pharmaceuticals.
Segmentation Analysis
By Type
• Prophylactic Vaccines (Infectious Diseases)
• Therapeutic Vaccines (Cancer, Chronic Diseases)
• Protein-Replacement mRNA Drugs
• Others
By Application
• Infectious Diseases (COVID-19, Influenza, HIV, Zika, Rabies, Others)
• Oncology (Solid Tumors, Hematologic Malignancies)
• Rare Genetic Disorders
• Cardiovascular & Metabolic Diseases
• Autoimmune & Inflammatory Conditions
By Technology
• Lipid Nanoparticles (LNPs)
• Polymer-Based Delivery Systems
• Cationic Emulsions
• Others
By End User
• Hospitals & Clinics
• Biopharma & Research Institutes
• Academic Centers
• Specialty Treatment Centers
Summary:
Infectious disease vaccines remain the largest segment, accounting for most revenues due to COVID-19 and influenza products. However, oncology and rare genetic disorders are expected to drive the fastest growth as new therapies gain clinical approval in the next decade.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72890/mrna-vaccine-and-therapeutics-market
Regional Analysis
North America
• Largest market share in 2024.
• Strong presence of Moderna, Pfizer-BioNTech collaborations, and extensive NIH funding.
• Favorable FDA support for emergency use and accelerated approvals.
Europe
• Second-largest share, driven by BioNTech (Germany), CureVac, and Sanofi.
• Significant EU funding for pandemic preparedness and biotech R&D.
Asia-Pacific
• Fastest-growing region, led by China, Japan, South Korea, and India.
• Rapid adoption of domestic mRNA platforms and vaccine manufacturing capacity expansion.
• Increasing government support for homegrown biotech firms.
Middle East & Africa
• Early-stage adoption but rising demand due to vaccination programs.
• Investments in biotech hubs in UAE, Saudi Arabia, and South Africa.
Latin America
• Brazil, Mexico, and Argentina drive regional growth.
• Local vaccine partnerships emerging to reduce import dependency.
Summary:
While North America and Europe dominate today, Asia-Pacific is projected to record the highest CAGR (12-13%) as regional biopharma investment accelerates.
Market Dynamics
Key Growth Drivers
• mRNA's versatility for infectious disease prevention and oncology.
• Rapid adaptability to emerging viral mutations.
• Robust investment by governments for pandemic preparedness.
• Collaborations between biotech startups and established pharma players.
Key Challenges
• Cold chain and storage requirements limiting global distribution.
• Regulatory uncertainties for novel therapeutic mRNAs.
• Public skepticism regarding new vaccine technologies.
Latest Trends
• Next-generation delivery systems improving stability beyond LNPs.
• Pan-coronavirus and universal influenza mRNA vaccines under development.
• Personalized cancer vaccines tailored to individual patient tumor profiles.
• mRNA combinations with gene-editing tools for rare genetic diseases.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72892
Competitor Analysis
Major Players:
• Pfizer Inc.
• BioNTech SE
• Moderna Inc.
• CureVac AG
• Sanofi
• Gilead Sciences
• Arcturus Therapeutics
• Translate Bio (Sanofi)
• AstraZeneca
• Vertex Pharmaceuticals
Competitive Landscape:
The market is consolidated by a few leaders (Moderna, Pfizer-BioNTech, CureVac) but rapidly evolving. Moderna's Spikevax and Pfizer-BioNTech's Comirnaty remain dominant products in infectious disease vaccines. Startups like Arcturus and CureVac are key innovators in next-generation delivery and oncology applications. Strategic partnerships, licensing, and government contracts are shaping the competitive race.
Conclusion
The global mRNA vaccine and therapeutics market is set to grow from USD 46.5 billion in 2024 to USD 127.8 billion by 2034, at a CAGR of 10.7%. While infectious diseases remain the largest revenue driver, oncology, rare genetic disorders, and personalized medicine represent the most promising areas for future growth.
Despite cold-chain and cost barriers, innovation in delivery technologies and expanding government support make this one of the most transformative segments in biopharma. With Asia-Pacific emerging as the fastest-growing market, global collaboration and investment are expected to accelerate breakthroughs in the next decade.
Key Takeaway: The mRNA revolution has only just begun. Companies that expand beyond infectious diseases into oncology and rare disorders, while mastering delivery platforms, will define the future of global healthcare.
This report is also available in the following languages : Japanese (mRNAワクチンと治療薬), Korean (mRNA 백신 및 치료제), Chinese (mRNA疫苗和治疗学), French (Vaccins et thérapies à ARNm), German (mRNA-Impfstoff und -Therapeutika), and Italian (Vaccino a mRNA e terapie), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72890
Our More Reports:
Neoantigen Targeted Therapies
https://exactitudeconsultancy.com/reports/73132/neoantigen-targeted-therapies-market
Pharmaceutical Caps and Closures
https://exactitudeconsultancy.com/reports/73134/pharmaceutical-caps-and-closures-market
Depressive Disorders
https://exactitudeconsultancy.com/reports/73136/depressive-disorders-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release mRNA Vaccine and Therapeutics Market to Hit USD 127.8 Billion by 2034, Growing at 10.7% CAGR here
News-ID: 4205448 • Views: …
More Releases from Exactitude Consultancy
Soft Micro Robots Market Prospects: Advancements Propelled by ETH Zurich Spin-of …
Soft micro robots-tiny, flexible robotic systems often smaller than a millimeter-are redefining possibilities in biomedicine, minimally invasive surgery, drug delivery, micro-manipulation, and advanced materials research. Unlike rigid robots, these bio-inspired systems are designed to navigate complex, delicate environments such as the human body, offering unprecedented control, safety, and precision.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/75167
With advancements in soft materials, microfabrication, artificial intelligence, and wireless actuation techniques (magnetic,…
cGAS-STING Pathway Market to Hit USD 5.2 Billion by 2034, Growing at 14.7% CAGR
Introduction
The cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway has emerged as a pivotal discovery in immunology, acting as a critical sensor of cytosolic DNA and activating innate immune responses. This pathway plays a central role in antiviral defense, cancer immunology, and autoimmune diseases, making it a prime therapeutic target.
Over the last decade, pharmaceutical and biotech companies have intensified their focus on modulating the cGAS-STING pathway. From developing small-molecule agonists…
T-Cell Lymphoma Market to Reach USD 5.6 Billion by 2034, Growing at 10.4% CAGR
Introduction
T-cell lymphomas are a rare but aggressive group of non-Hodgkin's lymphomas (NHL) that originate from T-lymphocytes, accounting for about 10-15% of all NHL cases. They include diverse subtypes such as peripheral T-cell lymphoma (PTCL), cutaneous T-cell lymphoma (CTCL), and anaplastic large cell lymphoma (ALCL). Due to their heterogeneity and poor prognosis compared to B-cell lymphomas, treatment remains a major clinical challenge.
In recent years, the market has seen a surge in…
Machine Tool Contact Probe Market Prospects: Accurate Developments Driven by Hex …
Machine tool contact probes are critical components in modern manufacturing, enabling precise measurement, part alignment, and tool-setting directly on CNC machines. By improving accuracy, reducing downtime, and automating inspection processes, these probes are helping industries achieve higher efficiency and better quality control.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/75169
With the rise of Industry 4.0, smart factories, and demand for precision engineering, contact probes are becoming essential in automotive,…
More Releases for Bio
Human Plasma Products Market 2023: Industry Future Trends | Takeda, CSL, Grifols …
The Human Plasma Products market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with…
Gene Therapy Products Market | Advantagene, Avalanche Bio, Bluebird Bio, Cellado …
The global gene therapy products market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the gene therapy products market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Bio-based Polymethyl Methacrylate (Bio-PMMA) Market 2023 | Detailed Report
The Bio-based Polymethyl Methacrylate (Bio-PMMA) report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research.
The Bio-based Polymethyl Methacrylate (Bio-PMMA) research report…
Bio Pharma Buffer Market – A comprehensive study by Key Players: Bio-Rad, Lonz …
Latest Market intelligence report released by HTF MI with title "COVID-19 Outbreak-Global Bio Pharma Buffer Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020" is designed covering micro level of analysis by manufacturers and key business segments. The COVID-19 Outbreak-Global Bio Pharma Buffer Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary…
IVIG Market Anticipated a Noteworthy CAGR during 2019-2024 & Companies Included …
A report added to the rich database of Qurate Business Intelligence, titled “World IVIG Market by Product Type, Players and Regions - Forecast to 2024”, provides a 360-degree overview of the Global market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market makes the…
Green & Bio-based Solvents Market Analysis, Demand, & Opportunities till 2023 | …
A latest research report titled as “Green & Bio-based Solvents Market for Paints & Coatings, Printing Inks, Commercial & Domestic Cleaning, Adhesives & Sealants, Pharmaceutical, Cosmetics, and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023” has been recently added to the vast portfolio of Market Research Reports Search Engine (MRRSE) online research offerings. This report is a professional and in-depth analysis on the…
